Sign up to receive our latest industry insights, news, and more.
The clinical development collaboration will evaluate NeuroLens in multiple sclerosis and related neuroimmunologic diseases
2026 Q2 Healthcare Market Report
2026 Q1 Healthcare Market Report
$21B in headline acquisitions, $4.3B in new venture funds, and biotech outperformance signal renewed momentum across healthcare
Strategic Dialogue Across Healthcare and Life Sciences
Strategic M&A and Targeted VC Fuel Healthcare Recovery
Strategic M&A Surges to Six-Year High Despite Public Market Headwinds
Collaboration Expands M&A Advisory Services to Institutional Investors and High-Net-Worth Individuals
Healthcare Equities Outperform Amid Market Volatility as Strategic M&A Activity Accelerates
Strategic Advisory and Capital Formation Services Drive Successful Fundraise for Innovative Healthcare Technology Company
Seasoned Healthcare Investment Banking Professional to Lead Healthcare & Life Science Advisory Team